PUBLICATION AND CONFIDENTIALITY. 11.1 The Information shall be developed, received and used by the Licensee solely in furtherance of the purposes set forth in this Agreement subject to the terms and conditions set forth in this Section 11.
11.2 The Licensee shall keep and use all of the Confidential Information in confidence and will not, without the University's prior written consent, disclose any Confidential Information to any person or entity, except those of the Licensee's officers, employees and professional advisors who require said Confidential Information in performing their obligations under this Agreement. The Licensee covenants and agrees that it will take commercially reasonable steps to limit the internal distribution of the Confidential Information to only those officers, employees and professional advisors who require said Confidential Information in performing their obligations under this Agreement and who have signed confidentiality and non-disclosure agreements.
11.3 The Licensee shall not use, either directly or indirectly, any Confidential Information for any purpose other than as set forth herein without the University's prior written consent.
11.4 If the Licensee is required by judicial or administrative process to disclose any or all of the Confidential Information, the Licensee shall promptly notify the University and allow the University reasonable time to oppose such process before disclosing any Confidential Information.
11.5 Notwithstanding any termination or expiration of this Agreement, the obligations created in this Section 11 shall survive and be binding upon the Licensee, its successors and assigns.
11.6 The University shall not be restricted from presenting at symposia, national or regional professional meetings, or from publishing in journals or other publications, accounts of its research relating to the Information, provided that with respect to Confidential Information only, the Licensee shall have been furnished copies of the disclosure proposed therefor at least 60 days in advance of the presentation or publication date and does not within 30 days after delivery of the proposed disclosure object to such presentation or publication. Any objection to a proposed presentation or publication shall specify the portions of the presentation or publication considered objectionable (the "Objectionable Material"). Upon receipt of notification from the Licensee that any proposed publication or disclosure contains Objectionable Material, the University and the...
PUBLICATION AND CONFIDENTIALITY. 8.1 It is the policy of FOUNDATION and Cornell to promote and safeguard free and open inquiry by faculty, students and others. To further this policy, FOUNDATION and Cornell shall retain the right to publish information described in Applications and Patents.
8.2 Both parties agree to keep any information identified as confidential by the disclosing party confidential using methods at least as stringent as each party uses to protect its own confidential information, except as may be necessary to maintain an action against LICENSEE for breach of this Agreement or to audit LICENSEE as specified under Section 5.8. “Confidential Information” shall include the progress report required under Section 4.7 and any other information marked confidential or accompanied by correspondence indicating such information is confidential exchanged between the parties hereto. The confidentiality and use obligations set forth above apply to all or any part of the Confidential Information disclosed hereunder except to the extent that:
PUBLICATION AND CONFIDENTIALITY. 5.1 UNIVERSITY, as an institution of higher education, engages in Testing Services that are compatible, consistent and beneficial to its role and mission of advancing educational opportunity, scientific knowledge, and providing for its dissemination and the transfer of technology related thereto. Therefore, significant results of testing activities on non-proprietary materials must be reasonably available for publication. Before publishing, UNIVERSITY agrees to give CLIENT a copy of any proposed publication and CLIENT shall have six (6) weeks to review the publication. UNIVERSITY shall consider CLIENT'S suggested modifications; however, with the exception of removal of information subject to the confidentiality of section 5.2, the decision of the UNIVERSITY as to what the publication shall contain is final.
5.2 UNIVERSITY, to the extent allowed by Montana law, agrees to keep confidential any CLIENT proprietary information supplied to it by CLIENT during the course of Testing Services performed by UNIVERSITY and designated as confidential, and such information will not be included in any published material without prior approval by CLIENT. CLIENT agrees that any data from experiments or tests using non-proprietary materials (controls or generic materials or samples) may be entered into UNIVERSITY database and be available for publication without approval by CLIENT.
PUBLICATION AND CONFIDENTIALITY. (a) The Sublicensee shall keep and use all of UBC’s Confidential Information in confidence and will not, without UBC’s prior written consent, disclose any of UBC’s Confidential Information to any person or entity, except those of the Sublicensee’s directors, officers, employees, technical consultants and professional advisors who require said Confidential Information in connection with the Sublicensee performing its obligations or exercising its rights under the Sublicense Agreement. The Sublicensee shall also covenant and agree that it will initiate and maintain an appropriate internal program limiting the internal distribution of UBC’s Confidential Information to only those directors, officers, employees, technical consultants and professional advisors who require said Confidential Information in connection with the Sublicensee performing its obligations or exercising its rights under the Sublicense Agreement and who are under obligations of confidentiality consistent to those of the License Agreement.
(b) The Sublicensee shall acknowledge that UBC shall not be restricted from presenting at symposia, national or regional professional meetings, or from publishing in journals or other publications, accounts of its research relating to the Technology and any Improvements (other than Licensee Owned Improvements) in accordance with the terms of the License Agreement.
PUBLICATION AND CONFIDENTIALITY. A. Background Intellectual Property and Project Intellectual Property of a Party, as well as other proprietary or confidential information of a Party, disclosed by that Party to the other in connection with the Research Project shall be received and held in confidence by the receiving Party and, except with the consent of the disclosing Party or as permitted under this Agreement, shall neither be used by the receiving Party nor disclosed by the receiving Party to others, provided that the receiving Party has notice that such information is regarded by the disclosing Party as proprietary or confidential. However, these confidentiality obligations shall not apply to use or disclosure by the receiving Party after such information is or becomes known to the public without breach of this provision or is or becomes known to the receiving Party from a source reasonably believed to be independent of the disclosing Party or is developed by or for the receiving Party independently of its disclosure by the disclosing Party.
B. Either Party may publish its results from the Research Project and each Party agrees to provide to the other a copy of any such publications at the time of submission. Whenever possible, the publishing Party shall provide the other Party a thirty (30) day period in which to review proposed publications, identify material on which patent applications should be filed, and submit other comments. Each Party will give serious and good-faith consideration to any comments received from the other, provided, however, that such comments are received in sufficient time so as not to delay publication. In the event that Company or University desire to provide confidential information to the other, such information will be marked in writing as confidential at the time it is provided or, if provided orally, identified as confidential at the time of disclosure and confirmed in writing within ten (10) days of the oral disclosure. Unless otherwise required by law, the receiving Party will maintain such information in confidence in the same manner in which it maintains its own confidential information. Confidential information does not include information which: is or becomes generally available in the public domain through no act of the receiving Party; or was independently known prior to receipt thereof or is subsequently discovered independently by an employee of the receiving Party who has no access to the information supplied under this Agreement; or is made...
PUBLICATION AND CONFIDENTIALITY. Paragraph 4.1 of the NWO Grant Rules is implemented and applicable here.
PUBLICATION AND CONFIDENTIALITY. 9.1 As between Inex and Alnylam, the confidentiality, non-use and publication provisions of Article 8 of the LCA shall apply to the Confidential Information of the parties. Notwithstanding any termination or expiration of this Agreement, such obligations shall survive and be binding upon the Recipient, its successors and assigns.
9.2 [Intentionally omitted]
9.3 [Intentionally omitted]
9.4 [Intentionally omitted]
9.5 [Intentionally omitted]
9.6 Alnylam acknowledges that the policies of the University require that the results of the University’s research be publishable, subject to Article 9.0
PUBLICATION AND CONFIDENTIALITY. 5.1 The parties reserve the right to publish or otherwise make public the data resulting from the Study. The party so wishing to publish or make public shall submit any such manuscript or release to the other party for comment thirty (30) days prior to publication or release.
5.2 Except as otherwise required by law or regulation, neither party shall release or distribute any materials or information containing the name of the other party or any of its employees without prior written approval by an authorized representative of the non-releasing party, but such approval shall not be unreasonably withheld.
5.3 Each party shall hold in confidence for three (3) years after the termination of this Agreement any confidential information identified as confidential and obtained from the other party during the course of this Study. Nothing herein, however, shall prevent Institution or any other component of System from using any information generated hereunder for ordinary research and educational purposes of a university.
PUBLICATION AND CONFIDENTIALITY. 6.1 The parties reserve the right to publish or otherwise make public the data resulting from the Study. The party so wishing to publish or make public shall submit any manuscript or release to the other party for comment 30 days prior to publication or release.
6.2 Except as otherwise required by law or regulation, neither party shall release or distribute any materials or information containing the name of the other party or any of its employees without prior written approval by an authorized representative of the non-releasing party, such approval shall not be unreasonably withheld.
6.3 Each party shall hold in confidence for 3 years after the termination of this Agreement any confidential information identified as confidential and obtained from the other party during the term of this Study. Nothing herein, however, shall prevent Institution or any other component of System from using any information generated hereunder for ordinary research and educational purposes.
PUBLICATION AND CONFIDENTIALITY. 6.1 Institution reserves the right to publish the results of the Study, with due regard to the protection of Sponsor’s confidential information. Institution will submit the manuscript of any proposed publication to Sponsor at least thirty (30) days before publication, and Sponsor shall have the right to review and comment upon the publication in order to protect Sponsor’s Confidential Information. Institution shall delete from such publication or release any of Sponsor’s Confidential Information. Upon Sponsor’s request, publication will be delayed up to sixty (60) additional days to enable Sponsor to secure adequate intellectual property protection of property of Sponsor that would be affected by said publication.
6.2 Except as otherwise required by law or regulation, neither party shall release or distribute any materials or information containing the name of the other party or any of its employees without prior written approval by an authorized representative of the non-releasing party, but such approval shall not be unreasonably withheld.
6.3 The parties may wish, from time to time, in connection with work contemplated under this Agreement, to disclose confidential information to each other, including, but not limited to, patent applications, technology or business plans and all information relating thereto; all proprietary biological, chemical or other materials; applications, formulas, manufacturing processes, basic scientific data, prior and ongoing clinical trial data and formulation information; and any other information designated in writing as “Confidential” by a party (“Confidential Information”). Each party agrees not to use the other party’s Confidential Information except for purposes expressly authorized in this Agreement, including Institution’s right to publish the results of the Study as specified in Section 6.1 herein. Each party shall not disclose any of the other party’s Confidential Information to third parties for a period of five (5) years from receipt thereof, provided that the recipient party’s obligation shall not apply to information that:
a. is already in the recipient party’s possession at the time of disclosure thereof;
b. is or later becomes part of the public domain through no fault of the recipient party;
c. is received from a third party having no obligations of confidentiality with respect thereto to the disclosing party;
d. is independently developed by the recipient party without any breach of this Agreement; or
e. is ...
